364 related articles for article (PubMed ID: 17223016)
21. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
[TBL] [Abstract][Full Text] [Related]
22. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
23. In vitro emergence of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates.
Villar HE; Santana G; Jugo MB; Perren P; Hidalgo M; Alonso P; Maccallini G
J Infect Dev Ctries; 2015 Feb; 9(2):218-21. PubMed ID: 25699499
[No Abstract] [Full Text] [Related]
24. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon.
Matar GM; Cuzon G; Araj GF; Naas T; Corkill J; Kattar MM; Nordmann P
Clin Microbiol Infect; 2008 Sep; 14(9):887-8. PubMed ID: 18844693
[No Abstract] [Full Text] [Related]
25. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.
Tokatlidou D; Tsivitanidou M; Pournaras S; Ikonomidis A; Tsakris A; Sofianou D
J Clin Microbiol; 2008 Mar; 46(3):1005-8. PubMed ID: 18199780
[TBL] [Abstract][Full Text] [Related]
26. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
27. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Conejo MC; Hernández JR; Pascual A
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
[TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
[TBL] [Abstract][Full Text] [Related]
29. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
Daikos GL; Markogiannakis A
Clin Microbiol Infect; 2011 Aug; 17(8):1135-41. PubMed ID: 21635663
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
Netikul T; Leelaporn A; Leelarasmee A; Kiratisin P
Int J Antimicrob Agents; 2010 Jun; 35(6):609-10. PubMed ID: 20189774
[No Abstract] [Full Text] [Related]
31. Update: detection of a verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae --- United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Sep; 59(37):1212. PubMed ID: 20864922
[TBL] [Abstract][Full Text] [Related]
32. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
[TBL] [Abstract][Full Text] [Related]
33. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
[No Abstract] [Full Text] [Related]
34. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.
Meletis G; Tzampaz E; Sianou E; Tzavaras I; Sofianou D
J Antimicrob Chemother; 2011 Apr; 66(4):946-7. PubMed ID: 21393203
[No Abstract] [Full Text] [Related]
35. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
[No Abstract] [Full Text] [Related]
36. Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, July 2011.
McDermott H; Morris D; McArdle E; O'Mahony G; Kelly S; Cormican M; Cunney R
Euro Surveill; 2012 Feb; 17(7):. PubMed ID: 22370013
[TBL] [Abstract][Full Text] [Related]
37. Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.
Papagiannitsis CC; Giakkoupi P; Vatopoulos AC; Tryfinopoulou K; Miriagou V; Tzouvelekis LS
Int J Antimicrob Agents; 2010 Dec; 36(6):573-4. PubMed ID: 20863669
[No Abstract] [Full Text] [Related]
38. Multiclonal emergence of carbapenem-resistant Klebsiella pneumoniae in Tuscany, Italy.
Mammina C; Aleo A; Bonura C; Calà C; Degl'Innocenti R; Conti A; Pecile P; Pesavento G; Nastasi A
Int J Antimicrob Agents; 2010 Dec; 36(6):576-8. PubMed ID: 20869854
[No Abstract] [Full Text] [Related]
39. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Rapp RP; Urban C
Pharmacotherapy; 2012 May; 32(5):399-407. PubMed ID: 22488420
[TBL] [Abstract][Full Text] [Related]
40. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
